关注
Thomas Kryza
Thomas Kryza
Senior Research Officer, Mater Research Institite - The Universitu of Queensland
在 mater.uq.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
The kallikrein-related peptidase family: Dysregulation and functions during cancer progression
T Kryza, ML Silva, D Loessner, N Heuzé-Vourc'h, JA Clements
Biochimie 122, 283-299, 2016
1032016
Post-GWAS in prostate cancer: from genetic association to biological contribution
S Farashi, T Kryza, J Clements, J Batra
Nature Reviews Cancer 19 (1), 46-59, 2019
972019
Remodelling of the tumour microenvironment by the kallikrein-related peptidases
S Srinivasan, T Kryza, J Batra, J Clements
Nature Reviews Cancer 22 (4), 223-238, 2022
462022
Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis
E Dalloneau, N Baroukh, K Mavridis, A Maillet, F Gueugnon, Y Courty, ...
Oncotarget 7 (34), 54415, 2016
452016
Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
F Brellier, E Martina, M Degen, N Heuzé-Vourc’h, A Petit, T Kryza, ...
BMC clinical pathology 12, 1-10, 2012
432012
The CDCP1 signaling hub: a target for cancer detection and therapeutic intervention
T Khan, T Kryza, NJ Lyons, Y He, JD Hooper
Cancer research 81 (9), 2259-2269, 2021
402021
Revisiting glycogen in cancer: a conspicuous and targetable enabler of malignant transformation
T Khan, MA Sullivan, JH Gunter, T Kryza, N Lyons, Y He, JD Hooper
Frontiers in Oncology 10, 592455, 2020
372020
Angiogenesis stimulated by human kallikrein‐related peptidase 12 acting via a platelet‐derived growth factor B‐dependent paracrine pathway
T Kryza, C Achard, C Parent, S Marchand‐Adam, A Guillon‐Munos, ...
The FASEB Journal 28 (2), 740-751, 2014
362014
Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
N Bock, A Shokoohmand, T Kryza, J Röhl, J Meijer, PA Tran, CC Nelson, ...
Bone Research 7 (1), 13, 2019
282019
In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer
N Bock, T Kryza, A Shokoohmand, J Röhl, A Ravichandran, ML Wille, ...
Science advances 7 (27), eabg2564, 2021
272021
Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
T Kryza, T Khan, S Puttick, C Li, KA Sokolowski, WC Brian, T Cuda, ...
Theranostics 10 (9), 4116, 2020
272020
Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
LM Silva, T Stoll, T Kryza, CR Stephens, ML Hastie, HF Irving-Rodgers, ...
Scientific reports 7 (1), 6789, 2017
262017
Kallikrein‐related peptidase 4 induces cancer‐associated fibroblast features in prostate‐derived stromal cells
T Kryza, LM Silva, N Bock, RA Fuhrman‐Luck, CR Stephens, J Gao, ...
Molecular Oncology 11 (10), 1307-1329, 2017
242017
Integration of two in-depth quantitative proteomics approaches determines the kallikrein-related peptidase 7 (KLK7) degradome in ovarian cancer cell secretome
LM Silva, T Kryza, T Stoll, C Hoogland, Y Dong, CR Stephens, ML Hastie, ...
Molecular & Cellular Proteomics 18 (5), 818-836, 2019
222019
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1
T Kryza, T Khan, S Lovell, BS Harrington, J Yin, S Porazinski, M Pajic, ...
Nature chemical biology 17 (7), 776-783, 2021
192021
A suite of activity-based probes to dissect the KLK activome in drug-resistant prostate cancer
S Lovell, L Zhang, T Kryza, A Neodo, N Bock, E De Vita, ED Williams, ...
Journal of the American Chemical Society 143 (23), 8911-8924, 2021
192021
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
BS Harrington, Y He, T Khan, S Puttick, PJ Conroy, T Kryza, T Cuda, ...
Theranostics 10 (5), 2095, 2020
192020
Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix
T Kryza, C Parent, J Pardessus, A Petit, J Burlaud-Gaillard, P Reverdiau, ...
Scientific reports 8 (1), 6331, 2018
192018
Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor
T Kryza, G Lalmanach, M Lavergne, F Lecaille, P Reverdiau, Y Courty, ...
Biological chemistry 394 (3), 385-391, 2013
182013
GelMA, click-chemistry gelatin and bioprinted polyethylene glycol-based hydrogels as 3D ex vivo drug testing platforms for patient-derived breast Cancer Organoids
N Bock, F Forouz, L Hipwood, J Clegg, P Jeffery, M Gough, ...
Pharmaceutics 15 (1), 261, 2023
172023
系统目前无法执行此操作,请稍后再试。
文章 1–20